SITC meeting banner

SITC (Booth 431)

November 1, 2023 - November 5, 2023
San Diego, CA
Learn More

WuXi AppTec provides a full spectrum of services to support immuno-oncology research, covering all major target classes and therapeutic modalities.  Our world-class discovery platform includes cutting-edge capabilities in CAR T cell therapy, biomarker discovery, bispecific antibodies, tumor models, antibody-drug conjugates, and much more. We work collaboratively to rapidly advance programs from target discovery to candidate selection and into the clinic.

We are proud to present five scientific posters at this year’s SITC conference. While you’re in San Diego, join our poster presentations and visit us at Booth 431!

1 Administration of JAK and TYK2 inhibitor successfully ameliorates the severity of T cell transfer-induced colitis in mice446 Saturday
Nov. 4th
2Baricitinib treatment reduces the expansion of CD8+ T cells in C3H mice with skin grafts-induced alopecia areata452Saturday
Nov. 4th
3Combined inhibition of KRAS G12C and PD1 boosts the therapeutic efficacy via conditioning of tumor microenvironment
in pre-clinical humanized NSCLC mouse model
Nov. 4th
4Preclinical platform for nucleic acid drug evaluation: siRNA and mRNA therapeutics59Friday
Nov. 3rd
5Upregulation of drug metabolism enzymes mediates ADC resistance in a HER2-positive cancer cell line1162Saturday
Nov. 4th

Resource Links

WuXi AppTec Discovery Services

Resource Type: Brochure

Cancer Pharmacology Services

Resource Type: Brochure

Meet with Our Team